Over the years the European Medicines Regulatory Network has collected a wealth of data about clinical trials through their clinical trials registers,CTISandEudraCT. ACT EU is focused on engaging with the community of stakeholders to understand how data about clinical trials can address their needs. The stakeholders’ use cases are being collected to inform research priorities which may influence future public funding calls. By highlighting research needs and facilitating analysis of clinical trial data, ACT EU will inform better research and development of medicines and policy making in the European Union (EU).
ACT EU - Accelerating Clinical Trials · May 08, 2026
Clinical trials analytics
ACT EU initiative to collect stakeholder use cases and research priorities for analysis of clinical trial data from regulatory registers and CTIS.
Published by ACT EU - Accelerating Clinical Trials. HealthSignal links to the original document; the summary above is extracted from the source text.